Patent · US Active

Method for detection CPV 2a, 2b, and 2c and for discrimination wild type from vaccine type

US10233509B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 7, 2016
Grant dateMar 19, 2019
Priority date
Expiry dateDec 7, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention disclose a method for detection CPV 2a, 2b, and 2c in a sample by detecting VP2 gene. The signals can be detected by both fluorescent detection system and lateral flow immunochromatographic assay. The second object of this present invention is to provide a method to discriminate the wild type from the vaccine type. The first approach to achieve this object is discriminating wild type from vaccine type by SNP 36, which could be used on both fluorescent detection system and lateral flow immunochromatographic assay. The second approach to achieve this object is discriminating wild type from vaccine type by SNP 899 and SNP 963.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.